ARWRArrowhead Pharmaceuticals, Inc.Basing
TodayBasingnormal stock
Not sure what's inside? Read a full TSLA analysis, currently free
Technical readingsFree
Trend state Basing, stage 1 of 4, 3 of 4 damage flags raised (as of Oct 26, 2026)
Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 37.
Show all 12 readings
What unlocking ARWR reveals
Generated on unlock: written when ARWR's analysis runs, rather than checked against its stored data now.
Every section above, argued on ARWR's own numbers, on one page.
See what ARWR costsNot sure what's inside? Read a full TSLA analysis, currently freeUnlock the full ARWR analysis
AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.
- Unlocked in about 60 seconds
- No account needed
- Secure checkout via Stripe
Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
When does Arrowhead Pharmaceuticals, Inc. report earnings?
Arrowhead Pharmaceuticals, Inc. (ARWR) is scheduled to report earnings on Nov 24, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Oct 27, 2026
See who else reports soon